U Dirksen Selected Research

Nucleotides

10/2007

Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

U Dirksen Research Topics

Disease

14	Ewing Sarcoma (Sarcoma, Ewing) 09/2021 - 10/2007
11	Neoplasms (Cancer) 01/2020 - 11/2000
6	Sarcoma (Soft Tissue Sarcoma) 07/2019 - 03/2012
2	Neoplasm Metastasis (Metastasis) 11/2019 - 03/2010
1	Amenorrhea 01/2021
1	Necrosis 11/2019
1	Margins of Excision 11/2019
1	Osteosarcoma (Osteogenic Sarcoma) 01/2013
1	Disease Progression 01/2010
1	Primitive Neuroectodermal Tumors (PNET) 01/2010
1	Colorectal Neoplasms (Colorectal Cancer) 10/2007
1	Microsatellite Instability 10/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2006

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 07/2019 - 03/2012
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2012 - 07/2011
2	Proteins (Proteins, Gene)FDA Link 03/2012 - 10/2007
1	Hormones (Hormone)IBA 01/2021
1	Ifosfamide FDA LinkGeneric 08/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017
1	Alkylating AgentsIBA 08/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	EWS-FLI fusion proteinIBA 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	TrabectedinIBA 01/2016
1	CamptothecinIBA 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 11/2013
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2013
1	CytokinesIBA 03/2012
1	AntigensIBA 03/2012
1	Chimeric Antigen ReceptorsIBA 03/2012
1	GangliosidesIBA 03/2012
1	UbiquitinIBA 03/2012
1	Ligases (Synthetase)IBA 03/2012
1	NucleotidesIBA 10/2007
1	DNA (Deoxyribonucleic Acid)IBA 10/2007
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2007
1	Transforming Growth Factor-beta Type II ReceptorIBA 10/2007
1	Monoclonal AntibodiesIBA 11/2006
1	HLA-DR Antigens (HLA-DR)IBA 11/2006
1	CD19 AntigensIBA 11/2006
1	beta-Aminoethyl Isothiourea (AET)IBA 11/2000

Therapy/Procedure

6	Therapeutics 01/2020 - 11/2006
6	Drug Therapy (Chemotherapy) 11/2019 - 10/2007
4	Stem Cell Transplantation 09/2021 - 11/2000
1	Aftercare (After-Treatment) 01/2020
1	Combined Modality Therapy 01/2020
1	Radiotherapy 11/2019
1	Adjuvant Chemotherapy 07/2019